World

China’s D3 Bio Secures FDA Breakthrough and Orphan Drug Designations for KRAS G12C Inhibitor D3S-001

Breakthrough Therapy Designation was granted for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cel...

 August 29, 2025 | News

Pfizer And BioNTech Receive FDA Approval For LP.8.1-Adapted COVID-19 Vaccine For 2025-2026 Season

The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strain...

 August 28, 2025 | News

iNtRON Bio Files Patents for Groundbreaking IMPA™ Gene-Editing Technology Targeting Pasteurella Bacteriophages

Development of gene-editing technology for Pasteurella bacteriophages using the IMPA™ platform Establishment of an advanced platform tec...

 August 27, 2025 | News

AbbVie To Acquire Gilgamesh’s Lead Psychedelic Compound Bretisilocin For Up To $1.2 Billion

Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of m...

 August 26, 2025 | News

Esaote’s MyLab™ A50 and MyLab™ A70 Ultrasound Systems Achieve FDA Approval

Esaote – one of the world's leading medical imaging companies - is proud to announce that the MyLab™ A50 and MyLab™ A...

 August 25, 2025 | News

Piramal Pharma Solutions and NewAmsterdam Pharma Expand Global OSD Manufacturing with Facilities in USA and India

Piramal Pharma Solutions, a global leader in contract development and manufacturing (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), ...

 August 25, 2025 | News

Thermo Fisher Expands U.S. Footprint with New $192.5M Manufacturing Center in North Carolina

Thermo Fisher Scientific Inc., the world leader in serving science,  announced the grand opening of its innovative manufacturing center of excellence ...

 August 22, 2025 | News

XtalPi and Dong-A ST Sign MOU to Accelerate AI-Driven Drug Discovery in Immunology and Inflammation

 XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointl...

 August 21, 2025 | News

Spring Bio Solution to Launch LSPedia’s OneScan in India, Europe, and Singapore for Next-Generation Pharma Compliance

LSPedia, a leading provider of pharmaceutical compliance, serialization, and supply chain software solutions, today announced a strategic partnership with ...

 August 21, 2025 | News

Thermo Fisher Launches Gibco™ Expi293™ PRO System to Transform Protein Expression

Thermo Fisher Scientific has introduced the Gibco™ Expi293™ PRO Expression System, a next-generation HEK293 transient expression system designe...

 August 20, 2025 | News

LabConnect Launches LabConnector™ to Transform Clinical Trial Data Management

LabConnect, LLC, a global leader in central laboratory services for clinical trials, announced the launch of LabConnector™, a powerful new techn...

 August 20, 2025 | News

South Korea’s Avixgen, Subsidiary of Dx&Vx, Signs $360M Licensing-Out Deal with U.S. Biotech for ACP Drug Delivery Platform

This innovative platform technology, with exceptional scalability, has been recognized as highly valuable even with limited rights granted. DXVX is taki...

 August 19, 2025 | News

Anixa Biosciences Advances Phase 1 Trial of FSHR-Targeted CAR-T Therapy for Recurrent Ovarian Cancer

Anixa Biosciences, Inc.  a biotechnology company focused on the treatment and prevention of cancer,  announced that the second patient in th...

 August 19, 2025 | News

IQVIA and Veeva Forge Global Clinical and Commercial Partnerships, Resolve Legal Disputes

IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Und...

 August 19, 2025 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close